Zhejiang Huahai Pharmaceutical Co., Ltd.SSE: 600521

Indicative Announcement on Suspending Conversion of "Huahai Convertible Bonds" When Implementing Dividend Distribution for 2025

· Issued by Zhejiang Huahai Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Zhejiang Huahai Pharmaceutical Co., Ltd. has issued an indicative announcement regarding the suspension of the conversion of its convertible bonds during the implementation of its dividend distribution for the upcoming year. The announcement details that the suspension will occur from a specified date until the completion of the dividend distribution process. It also outlines the company's profit distribution plan, which includes a cash dividend per share for shareholders. The company assures that the announcement contains no false statements or omissions and is legally responsible for its accuracy.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Indicative Announcement on Suspending Conversion of "Huahai Convertible Bonds" When Implementing Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Huahai Pharmaceutical

Later from Zhejiang Huahai Pharmaceutical

All Zhejiang Huahai Pharmaceutical news releases